LKT Labs

Biochemicals for Life Science Research

Mefenamic Acid

Mefenamic Acid

Product ID M1622
Cas No. 61-68-7
Purity ≥98%
Product Unit SizeCostQuantityStock
10 g $41.00 In stock
50 g $72.00 In stock
100 g $102.00 In stock
Bulk Quote

Quicklinks

Description

Mefenamic acid is a fenamate non-steroidal anti-inflammatory drug (NSAID) that exhibits anti-inflammatory, analgesic, neuroprotective, anticancer, and neuromodulatory activities. Mefenamic acid is a non-selective inhibitor of COX-1 and COX-2 that also potentiates activity at GABA-A receptors. In animal models of cerebral ischemia, mefenamic acid decreases infarct volume, edema, and ischemic brain damage. Additionally, this compound inhibits proliferation in colon cancer cells by altering cell cycle regulators and inhibiting store-operated Ca2+ entry into cells.

Product Info

Cas No.

61-68-7
Purity

≥98%
Formula

C15H15NO2
Formula Wt.

241.29
Chemical Name

2-[(2,3-Dimethylphenyl)amino]benzoic acid
IUPAC Name

2-(2,3-dimethylanilino)benzoic acid
Synonym

Bonabol, Coslan, Lysalgo, Mefenacid, Ponstel, Tanston
Melting Point

230-231°C
Solubility

Insoluble in water. Sparingly soluble in ether and chloroform. Soluble in alkali hydroxide solutions.

Appearance

White Micro-Crystalline Powder

Shipping and Storage

Store Temp

Ambient
Ship Temp

Ambient

Downloads

MSDS

M1622 MSDS PDF
Info Sheet

M1622 Info Sheet PDF

References

Khansari PS, Halliwell RF. Evidence for neuroprotection by the fenamate NSAID, mefenamic acid. Neurochem Int. 2009 Dec;55(7):683-8. PMID: 19563851.

Weiss H, Amberger A, Widschwendter M, et al. Inhibition of store-operated calcium entry contributes to the anti-proliferative effect of non-steroidal anti-inflammatory drugs in human colon cancer cells. Int J Cancer. 2001 Jun 15;92(6):877-82. PMID: 11351310.

Halliwell RF, Thomas P, Patten D, et al. Subunit-selective modulation of GABAA receptors by the non-steroidal anti-inflammatory agent, mefenamic acid. Eur J Neurosci. 1999 Aug;11(8):2897-905. PMID: 10457186.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • V182685

    Verdinexor

    CRM1/XPO1 inhibitor.

    ≥99%
  • F4683

    Fluticasone Propionate

    β2-adrenergic agonist.

    ≥98%
  • G4518

    Glucaric Acid Calcium Tetrahydrate

    Oxidized non-cylic hexose sugar.

    ≥98%
  • N7209

    NSC-207895

    Benzofuroxan derivative; MDMX inhibitor.

    ≥98%
  • S3368

    S1RA

    σ1 antagonist.

    ≥99%
  • C1627

    Cefaclor Monohydrate

    β-lactam cephalosporin; penicillin binding pro...

    ≥97%
  • H6225

    HPGDS-inhibitor-1

    HPGDS inhibitor.

    ≥98%
  • O9397

    Oxytetracycline Hydrochloride

    Tetracycline; protein translation inhibitor.

    ≥95%
  • S520011

    SN-011

    STING antagonist

    ≥97%
  • I5440

    INK128

    mTOR inhibitor.

    ≥99%
  • T5870

    Torin 1

    Tricyclic benzonaphthyridinone; mTORC1/2 inhibi...

    ≥98%
  • P8167

    Puromycin Aminonucleoside

    Purine nucleoside analog; DNA chain terminator,...

    ≥98%
  • P4403

    Plasminogen Activator Inhibitor 1

    Endogenous peptide, produced by activation of P...

    ≥95%
  • P2997

    Phytic Acid, 40-50 wt% aqueous solution

    Saturated cyclic acid used to store phosphorus ...

    ≥40%
  • M3310

    Miconazole Nitrate

    Imidazole; 14-α demethylase inhibitor, potenti...

    ≥98%
  • J889280

    JWH 015

    Cannabinoid receptor 2 selective agonist.

    ≥98%
  • B3573

    Bisdemethoxycurcumin

    Curcumin derivative; DNMT1 and α-amylase inhib...

    ≥98%
  • O4532

    Oligomycin B

    Macrolide; F1F0 ATP synthase inhibitor.

    ≥97%, TLC, HPLC
  • I5992

    IOX2

    Prolyl hydroxylase inhibitor.

    ≥98%
  • D5753

    Donepezil Hydrochloride

    GSK3 and AChE inhibitor, potential σ1 agonist....

    ≥98%